NL0015000AG6 - Common Stock
LAVA THERAPEUTICS NV
NASDAQ:LVTX (5/2/2024, 7:05:34 PM)
3.1
+0.13 (+4.38%)
LAVA Therapeutics NV is an immuno-oncology company. The company is headquartered in Utrecht, Utrecht and currently employs 69 full-time employees. The company went IPO on 2021-03-29. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
LAVA THERAPEUTICS NV
Yalelaan 60
Utrecht UTRECHT
P: 31630003035
Employees: 69
Website: https://www.lavatherapeutics.com/
LVTX stock results show that LAVA Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips LAVA Therapeutics (NASDAQ:LVTX) just reported results for the fourth quarter of...
LAVA-1207 progressing in Phase 1/2a study, with pembrolizumab combination expected to begin in Q2 2024In March 2024, Pfizer paid LAVA $7 million for...
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END
Here you can normally see the latest stock twits on LVTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: